Adherence to Antiretroviral Therapy and Its Effect on Survival of HIV-Infected Individuals in Jharkhand, India

PLoS ONE

Volumn 8, Issue 6, 2013, Pages

  Rai, Sandeep ^a   Mahapatra, Bidhubhusan ^b   Sircar, Subhashish ^a   Raj, Pinnamaneni Yujwal ^c   Venkatesh, Srinivasan ^c   Shaukat, Mohammed ^c   Rewari, Bharat Bhusan ^c  

^a Jharkhand and Bihar State AIDS Control Society   (India)

^b POPULATION COUNCIL   (India)

^c GOVERNMENT OF INDIA   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ADULT; AGE DISTRIBUTION; AIDS RELATED COMPLEX; ANTIVIRAL THERAPY; ARTICLE; CD4 LYMPHOCYTE COUNT; COHORT ANALYSIS; DRUG USE; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INDIA; INTERVENTION STUDY; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MORTALITY; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; SURVIVAL RATE; SURVIVAL TIME; HIV INFECTIONS; PROPORTIONAL HAZARDS MODEL; RETROSPECTIVE STUDY;

ADULT; ANTI-HIV AGENTS; CD4 LYMPHOCYTE COUNT; FEMALE; HIV INFECTIONS; HUMANS; INDIA; MALE; PATIENT COMPLIANCE; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES;

EID: 84879146007     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0066860     Document Type: Article

References (36)

1. Wood E, Hogg RS, Yip B, Harrigan PR, O'Shaughnessy MV, et al. (2003) Effect of Medication Adherence on Survival of HIV-Infected Adults Who Start Highly Active Antiretroviral Therapy When the CD4+ Cell Count Is 0.200 to 0.350×109 cells/L. Annals of Internal Medicine 139: 810-816.
2. Abaasa AM, Todd J, Ekoru K, Kalyango JN, Levin J, et al. (2008) Good adherence to HAART and improved survival in a community HIV/AIDS treatment and care programme: the experience of The AIDS Support Organization (TASO), Kampala, Uganda. BMC Health Serv Res 8: 241 10.1186/1472-6963-8-241.
3. Mills EJ, Bakanda C, Birungi J, Chan K, Ford N, et al. (2011) Life expectancy of persons receiving combination antiretroviral therapy in low-income countries: a cohort analysis from Uganda. Ann Intern Med 155: 209-216 10.1059/0003-4819-155-4-201108160-00358.
4. Chi BH, Cantrell RA, Zulu I, Mulenga LB, Levy JW, et al. (2009) Adherence to first-line antiretroviral therapy affects non-virologic outcomes among patients on treatment for more than 12 months in Lusaka, Zambia. Int J Epidemiol 38: 746-756 10.1093/ije/dyp004.
5. Reda AA, Biadgilign S, (2012) Determinants of Adherence to Antiretroviral Therapy among HIV-Infected Patients in Africa. AIDS Research and Treatment 2012: 8 10.1155/2012/574656.
6. Joglekar N, Paranjape R, Jain R, Rahane G, Potdar R, et al. (2011) Barriers to ART adherence & follow ups among patients attending ART centres in Maharashtra, India. Indian J Med Res 134: 954-959 10.4103/0971-5916.92642.
7. Sahay S, Reddy KS, Dhayarkar S, (2011) Optimizing adherence to antiretroviral therapy. Indian J Med Res 134: 835-849 10.4103/0971-5916.92629.
8. Gross R, Yip B, Lo Re V 3rd, Wood E, Alexander CS, et al (2006) A simple, dynamic measure of antiretroviral therapy adherence predicts failure to maintain HIV-1 suppression. J Infect Dis 194: 1108-1114 10.1086/507680.
9. Mills EJ, Nachega JB, Bangsberg DR, Singh S, Rachlis B, et al. (2006) Adherence to HAART: a systematic review of developed and developing nation patient-reported barriers and facilitators. PLoS Med 3: e438 10.1371/journal.pmed.0030438.
10. Bachani D, Garg R, Rewari BB, Hegg L, Rajasekaran S, et al. (2010) Two-year treatment outcomes of patients enrolled in India's national first-line antiretroviral therapy programme. Natl Med J India 23: 7-12.
11. Sogarwal R, Bachani D, (2009) Assessment of ART centres in India: client perspectives. J Indian Med Assoc 107: 276-280.
12. Venkatesh KK, Srikrishnan AK, Mayer KH, Kumarasamy N, Raminani S, et al. (2010) Predictors of nonadherence to highly active antiretroviral therapy among HIV-infected South Indians in clinical care: implications for developing adherence interventions in resource-limited settings. AIDS Patient Care STDS 24: 795-803 10.1089/apc.2010.0153.
13. Batavia AS, Balaji K, Houle E, Parisaboina S, Ganesh AK, et al. (2010) Adherence to antiretroviral therapy in patients participating in a graduated cost recovery program at an HIV care center in South India. AIDS Behav 14: 794-798 10.1007/s10461-009-9663-6.
14. Cauldbeck MB, O'Connor C, O'Connor MB, Saunders JA, Rao B, et al. (2009) Adherence to anti-retroviral therapy among HIV patients in Bangalore, India. AIDS Res Ther 6: 7 10.1186/1742-6405-6-7.
15. Lal V, Kant S, Dewan R, Rai SK, Biswas A, (2010) A two-site hospital-based study on factors associated with nonadherence to highly active antiretroviral therapy. Indian J Public Health 54: 179-183 10.4103/0019-557X.77256.
16. Rajasekaran S, Jeyaseelan L, Vijila S, Gomathi C, Raja K, (2007) Predictors of failure of first-line antiretroviral therapy in HIV-infected adults: Indian experience. AIDS 21Suppl 4: S47-53 10.1097/01.aids.0000279706.24428.78.
17. National AIDS Control Organisation (NACO) (2011) National AIDS control programme- Phase III: State fact sheets. New Delhi, India: NACO. Available at: Accessed on.
18. International Institute for Population Sciences (IIPS) (2010) District Level Household and Facility Survey (DLHS-3), 2007-08: India: Key Indicators: States and Districts. Mumbai, India: IIPS. Available at: Accessed on.
19. Kumarasamy N, Solomon S, Chaguturu SK, Cecelia AJ, Vallabhaneni S, et al. (2005) The changing natural history of HIV disease: before and after the introduction of generic antiretroviral therapy in southern India. Clin Infect Dis 41: 1525-1528 10.1086/497267.
20. Teja VD, Sudha T, Lakshmi V, (2007) Causes and pattern of mortality in HIV-infected, hospitalized patients in a tertiary care hospital: a fourteen year study. Indian J Med Sci 61: 555-561.
21. Jha P, Kumar R, Khera A, Bhattacharya M, Arora P, et al. (2010) HIV mortality and infection in India: estimates from nationally representative mortality survey of 1.1 million homes. BMJ 340: c621 10.1136/bmj.c621.
22. Ghate M, Deshpande S, Tripathy S, Godbole S, Nene M, et al. (2011) Mortality in HIV infected individuals in Pune, India. Indian J Med Res 133: 414-420.
23. Lima VD, Harrigan R, Murray M, Moore DM, Wood E, et al. (2008) Differential impact of adherence on long-term treatment response among naive HIV-infected individuals. AIDS 22: 2371-2380 10.1097/QAD.0b013e328315cdd3.
24. Mermin J, Were W, Ekwaru JP, Moore D, Downing R, et al. (2008) Mortality in HIV-infected Ugandan adults receiving antiretroviral treatment and survival of their HIV-uninfected children: a prospective cohort study. Lancet 371: 752-759 10.1016/S0140-6736(08)60345-1.
25. Braitstein P, Brinkhof MW, Dabis F, Schechter M, Boulle A, et al. (2006) Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries. Lancet 367: 817-824 10.1016/S0140-6736(06)68337-2.
26. Stringer JS, Zulu I, Levy J, Stringer EM, Mwango A, et al. (2006) Rapid scale-up of antiretroviral therapy at primary care sites in Zambia: feasibility and early outcomes. JAMA 296: 782-793 10.1001/jama.296.7.782.
27. de Olalla PG, Knobel H, Carmona A, Guelar A, López-Colomés JL, et al. (2002) Impact of Adherence and Highly Active Antiretroviral Therapy on Survival in HIV-Infected Patients. JAIDS Journal of Acquired Immune Deficiency Syndromes 30: 105-110.
28. Maggiolo F, Airoldi M, Kleinloog HD, Callegaro A, Ravasio V, et al. (2007) Effect of adherence to HAART on virologic outcome and on the selection of resistance-conferring mutations in NNRTI- or PI-treated patients. HIV Clin Trials 8: 282-292 10.1310/hct0805-282.
29. Nachega JB, Mills EJ, Schechter M, (2010) Antiretroviral therapy adherence and retention in care in middle-income and low-income countries: current status of knowledge and research priorities. Curr Opin HIV AIDS 5: 70-77 10.1097/COH.0b013e328333ad61.
30. Chan KC, Yip B, Hogg RS, Montaner JS, O'Shaughnessy MV, (2002) Survival rates after the initiation of antiretroviral therapy stratified by CD4 cell counts in two cohorts in Canada and the United States. AIDS 16: 1693-1695.
31. Taylor-Smith K, Tweya H, Harries A, Schoutene E, Jahn A, (2010) Gender differences in retention and survival on antiretroviral therapy of HIV-1 infected adults in Malawi. Malawi Med J 22: 49-56.
32. Alonso Gonzalez M, Martin L, Munoz S, Jacobson J, (2011) Patterns, trends and sex differences in HIV/AIDS reported mortality in Latin American countries: 1996-2007. BMC Public Health 11: 605.
33. Arrivillaga M, Ross M, Useche B, Alzate ML, Correa D, (2009) Social position, gender role, and treatment adherence among Colombian women living with HIV/AIDS: social determinants of health approach. Rev Panam Salud Publica 26: 502-510.
34. Wagner JH, Justice AC, Chesney M, Sinclair G, Weissman S, et al. (2001) Patient- and provider-reported adherence: toward a clinically useful approach to measuring antiretroviral adherence. Journal of clinical epidemiology 54: S91-S98.
35. Minzi OM, Naazneen AS, (2008) Validation of self-report and hospital pill count using unannounced home pill count as methods for determination of adherence to antiretroviral therapy. Tanzan J Health Res 10: 84-88.
36. Kunutsor S, Evans M, Thoulass J, Walley J, Katabira E, et al. (2010) Ascertaining baseline levels of antiretroviral therapy adherence in Uganda: a multimethod approach. J Acquir Immune Defic Syndr 55: 221-224 10.1097/QAI.0b013e3181e255ec.